Modernising Subject Payments in Clinical Trials
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-17.pdf
Continue Reading →
Clinical Research v3i3
Managing the Use of Research- Grade Kits During Clinical Trials
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-16.pdf
Continue Reading →
Clinical Research v3i3
Feasibility, Risk Management and Clinical Trials – Art or Science?
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-15.pdf
Continue Reading →
Clinical Research v3i3
Optimising Clinical Research Site Performance through Additive Patient Enrolment
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-14.pdf
Continue Reading →
Clinical Research v3i3
Business Partnering – The Way Forward for Cryogenics
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-13.pdf
Continue Reading →
Clinical Research v3i3
Determination of Efficacy of AnvirzelTM in 37 Established Cancer Cell Lines
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-12.pdf
Continue Reading →
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
IPI Media © 2024, All Rights Reserved – Powered by Teksyte